Related Experiment Video
Updated: Feb 17, 2026

Author Spotlight: Optimizing Antibody-Based Cancer Treatments via Antibody-Dependent, Cell-Mediated Cytotoxicity Assay
Published on: September 13, 2024
Thyroid dysfunctions secondary to cancer immunotherapy.
P Chalan1, G Di Dalmazi1,2, F Pani1,3
1Division of Immunology, Department of Pathology, The Johns Hopkins School of Medicine, Ross Building-Room 656, 720 Rutland Avenue, Baltimore, MD, 21205, USA.
Cancer immunotherapy, particularly immune checkpoint inhibitors, can cause thyroid dysfunction. Patients receiving these treatments require regular monitoring of their thyroid health to detect and manage potential adverse events.
Area of Science:
- Oncology
- Immunology
- Endocrinology
Background:
- Cancer immunotherapy is a key treatment modality alongside surgery, radiotherapy, and chemotherapy.
- Immunotherapy can lead to immune-related adverse events, including thyroid dysfunction.
Purpose of the Study:
- To review immunotherapy types, mechanisms, and their association with thyroid dysfunction.
- To analyze the incidence of thyroid dysfunction across different immunotherapy strategies.
Main Methods:
- A comprehensive literature search of MEDLINE was conducted.
- Data was collected for articles published up to March 30, 2017.
Main Results:
- Early immunotherapies (cytokines) caused thyroid dysfunction in 1-50% of patients.
- Immune checkpoint inhibitors (anti-CTLA-4, anti-PD-1, anti-PD-L1) are linked to a high risk of thyroid autoimmunity, especially anti-PD-1 and combination therapies.
- Oncolytic viruses, adoptive T-cell transfer, and cancer vaccines rarely cause thyroid dysfunction.
Conclusions:
- Monoclonal antibodies targeting immune checkpoints increase the risk of thyroid dysfunction in cancer patients.
- Baseline and periodic assessment of thyroid function is crucial for patients undergoing immune checkpoint inhibitor therapy.
Related Concept Videos
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Psychoneuroimmunology: Diabetes and Cancer
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
The Tumor Microenvironment

